First Responder COVID-19 Vaccine 3rd and Booster Doses
The Department of Public Safety strives to administer COVID-19 vaccines in accordance with all program requirements and conditions of the CDC, ACIP, and FDA. CDC recommends those with moderate to severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments receive a 3rd dose of COVID-19 mRNA vaccine after completing their 2-dose mRNA vaccine series.
Moderate to severe immune compromise conditions include, but are not limited to:
- Active treatment (not history) for any cancer including chemotherapy, radiation therapy, or surgery within 2 years
- Receipt of solid-organ transplant and currently taking immunosuppressive therapy
- Receipt of CAR-T-cell or hematopoietic stem cell transplant (within 2 years of transplantation or taking immunosuppression therapy)
- Moderate or severe primary immunodeficiency (e.g., DiGeorge syndrome, Wiskott-Aldrich syndrome)
- Advanced or untreated HIV infection
- Active treatment with high-dose corticosteroids (i.e., ≥20mg prednisone or equivalent per day), transplant-related immunosuppressive drugs, cancer chemotherapeutic agents classified as severely immunosuppressive, tumor-necrosis (TNF) blockers, and other biologic agents that are immunosuppressive or immunomodulatory such as:
- Steroids – daily or regular doses of prednisone, prednisolone, or decadron (not single-injection) at a daily dose greater than or equal to 20 mg prednisone or equivalent per day.
- Alkylating agents and antimetabolites used for chemotherapy (examples include Cisplatin, Cyclophosphamide, 5-FU, and Methotrexate).
- TNF blockers such as adalimumab (Humira), etanercept (Enbrel), infliximab (Remicade), golimumab (Simponi) most commonly used for the treatment of rheumatoid arthritis, psoriasis, ulcerative colitis/Crohn’s disease, or ankylosing spondylitis.
- Transplant anti-rejection (immunosuppressant) medications such as tacrolimus (Prograf), cyclosporine (Neoral), Imuran (Azathioprine), Rapamune (Rapamycin), and Micophenolate (CellCept)
Other conditions, treatments, or medications may result in an individual being characterized as moderately or severely immunocompromised. If you are uncertain about whether you meet one of the qualifications listed above, please consult with your primary care physician.
In addition, those who have received two doses of the Pfizer-BioNTech’s COVID-19 vaccination should receive a booster of vaccine at least six months after the 2nd dose if you are:
- Age 65 and older;
- 18 years and older but living in a long-term care setting; or
- Age 50-64 with underlying medical conditions.
Lastly, CDC recommends that individuals who meet the following conditions may receive a booster dose of Pfizer-BioNTech vaccine at least six months after their 2nd dose based on individual benefits and risks:
- Age 18-49 years with underlying medical conditions; or
- Age 18-64 years and at increased risk of COVID-19 exposure and transmission because of occupational or institutional setting (includes first responders).
The Department of Public Safety is pleased to offer private first-responder clinics providing 3rd doses of Pfizer and Moderna vaccines and booster doses of Pfizer, as well as seasonal influenza (flu) vaccines (separate registration page). First responders (EMS personnel, law enforcement, firefighters, and emergency management officials) who meet any of the above criteria are welcome to schedule themselves at a Department of Public Safety clinic using the links below.
Individuals should bring their existing vaccination card and are required to sign a self-attestation form to confirm their eligibility for a third or booster dose. Third doses must match the vaccine individuals received for their first and second dose (i.e., if your first two doses were Moderna vaccine, your third dose must be Moderna vaccine as well). Booster doses are authorized for the Pfizer vaccine ONLY. Booster or additional doses are not currently recommended for those who have received the Janssen (J&J) vaccine.
All clinics will be hosted at the Public Safety Training Campus (1175 Conshohocken Road, Conshohocken, PA 19428) in a drive-through fashion in the back of the building.
|Tuesday||10/12/2021||10 AM - 12 PM||https://vaccinations.health.pa.gov/appointment/en/reg/0515296055|
|Thursday||10/14/2021||2 PM - 4 PM||https://vaccinations.health.pa.gov/appointment/en/reg/9010256505|
If you have not yet received a COVID vaccine and would like to get vaccinated, please click here.